Primary antimicrobial resistance among Mycobacterium tuberculosis isolates from HIV seropositive and HIV seronegative patients in Dar es Salaam Tanzania

BMC Research Notes

Volumn 1, Issue , 2008, Pages

  Urassa, Willy ^a   Mugusi, Ferdinand ^a   Villamor, Eduardo ^c   Msamanga, Gernard ^a   Moshiro, Candida ^a   Bosch, Ronald ^c   Saathoff, Elmar ^b   Fawzi, Wafaie ^c  

^a MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^b Department of Infectious Diseases and Tropical Medicine ^*  (Germany)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 62449176784     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-1-58     Document Type: Article

References (23)

1. Global surveillance for anti-tuberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. A Pablos-Méndez MC Raviglione A Laszlo N Binkin HL Rieder F Bustreo DL Cohn CS Lambregts-van Weezenbeek SJ Kim P Chaulet P Nunn, N Engl J Med 1998 338 23 1641 9 10.1056/NEJM199806043382301 9614254
2. The global situation of MDR-TB. MA Espinal, Tuberculosis (Edinb) 2003 83 1-3 44 51 10.1016/S1472-9792(02)00058-6 12758188
3. The World Health Organization/International Union Against Tuberculosis and Lung Disease. Global project on surveillance for anti-tuberculosis drug resistance: a model for other infectious diseases. MA Aziz A Wright, Clin Infect Dis 2005 15;41 Suppl 4 258 62 10.1086/430786 (Pubitemid 41099620)
4. Anti-tuberculosis drug resistance in the world report no. 4. WHO, The WHO/IUATLD global project on anti-tuberculosis surveillance 2002-2007
5. Tuberculosis due to resistant Haarlem strain, Tunisia. H Mardassi A Namouchi R Haltiti M Zarrouk B Mhenni A Karboul N Khabouchi NC Gey van Pittius EM Streicher J Rauzier B Gicquel K Dellagi, Emerg Infect Dis 2005 11 6 957 61 15963297
6. Mycobacterium tuberculosis Beijing genotype, northern Malawi. JR Glynn AC Crampin H Traore MD Yates FD Mwaungulu BM Ngwira SD Chaguluka DT Mwafulirwa S Floyd C Murphy FA Drobniewski PE Fine, Emerg Infect Dis 2005 11 1 150 3 15705343
7. Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: clues from human phylogeography. I Mokrousov HM Ly T Otten NN Lan B Vyshnevskyi S Hoffner O Narvskaya, Genome Res 2005 15 10 1357 64 16169923 10.1101/gr.3840605 (Pubitemid 41400901)
8. MIRU-VNTR genotyping of Mycobacterium tuberculosis strains from Siberia: Beijing versus Kilimanjaro family. TV Medvedeva OB Ogarkov OM Nekipelov ES Koziakova RG Skvortsova, Mol Gen Mikrobiol Virusol 2004 4 33 8 15597570
9. Drug resistance of Mycobacterium tuberculosis in selected urban and rural areas in Bangladesh. K Zaman Z Rahim M Yunus S Arifeen A Baqui D Sack S Hossain S Banu MA Islam J Ahmed R Breiman R Black, Scand J Infect Dis 2005 37 1 21 6 10.1080/00365540410026095 15764186
10. Drug-resistant tuberculosis in Kaunas region 1997-2001. A Naudziunas A Andriuskeviciene, Medicina (Kaunas) 2003 39 1 30 5 12576763
11. Susceptibility pattern and epidemiology of Mycobacterium tuberculosis in a Saudi Arabian hospital: a 15-year study from 1989 to 2003. JA Al-Tawfiq AA Al-Muraikhy MS Abed, Chest 2005 128 5 3229 32 10.1378/chest.128.5.3229 16304266
12. Drug resistance of Mycobacterium tuberculosis complex in central Taiwan. CE Liu CH Chen JH Hsiao TG Young RW Tsay CP Fung, J Microbiol Immunol Infect 2004 37 5 295 300 15497011
13. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey. M Sanders A Van Deun D Ntakirutimana D Ntakirutimana JP Masabo J Rukundo L Rigouts K Fissette F Portaelst, Int J Tuberc Lung Dis 2006 10 2 178 83 16499257
14. An alarming rate of drug-resistant tuberculosis at Ngwelezane Hospital in northern KwaZulu Natal, South Africa. J Lin AN Sattar T Puckree, Int J Tuberc Lung Dis 2004 8 5 568 73 15137532
15. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. E Kassa-Kelembho G Bobossi-Serengbe EC Takeng TB Nambea-Koisse F Yapou A Talarmin, Int J Tuberc Lung Dis 2004 8 5 574 8 15137533
16. Isolation of multidrug-resistant tuberculosis strains in patients from private and public health care facilities in Nairobi, Kenya. WA Githui HK Meme ES Juma P Kinyanjui F Karimi JM Chakaya J Kangangi A Kutwa, Int J Tuberc Lung Dis 2004 8 7 837 41 15260274
17. The impact of the HIV epidemic on tuberculosis transmission in Tanzania. SM Egwaga FG Cobelens H Muwinge C Verhage N Kalisvaart MW Borgdorff, AIDS 2006 20 6 915 21 10.1097/01.aids.0000218557.44284.83 16549977
18. DNA fingerprinting and phenotyping of Mycobacterium tuberculosis isolates from human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients in Tanzania. ZH Yang I Mtoni M Chonde M Mwasekaga K Fuursted DS Askgård J Bennedsen PE de Haas D van Soolingen JD van Embden, J Clin Microbiol 1995 33 5 1064 9 7615706
19. An epidemiological study of tuberculosis and HIV infection in Tanzania, 1991-1993. HJ Chum RJ O'Brien TM Chonde P Graf HL Rieder, AIDS 1996 10 3 299 309 10.1097/00002030-199603000-00009 8882670
20. HIV co-infection, CD4 cell counts and clinical correlates of bacillary density in pulmonary tuberculosis. F Mugusi E Villamor W Urassa E Saathoff RJ Bosch WW Fawzi, Int J Tuberc Lung Dis 2006 10 6 663 9 16776454
21. A trial of the micronutrients supplementation on treatment outcome, T cell counts, morbidity and mortality in adults with pulmonary tuberculosis. E Villamor F Mugusi W Urassa R Bosch E Saathoff K Matsumoto S Meydani W Fawzi, JID 2008 197 1 7 10.1086/587846 18171276
22. The accuracy of an alternative confirmatory strategy for detection of antibodies to HIV-1: Experience from a regional laboratory in Kagera, Tanzania. WK Urassa G Karina J Killewo G Kwesigabo A Mbakileki F Mhalu G Biberfeld, J Clin Virol 1999 14 25 9 10.1016/S1386-6532(99)00043-8 10548127
23. Global program on AIDS. Proposed criteria for interpretation of results from Western blot assay for HIV-1, HIV-2 and HTLV-II. WHO, Wkly Epidemiol Rec 1990 37 281 283